IVAC MEDICAL SYSTEMS, INC. – Trademark Portfolio
Entity Type: 03
IVAC MEDICAL SYSTEMS, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ACCUSLIDE and SMARTSITE. The owner is based in SAN DIEGO, CA.
10221 WATERIDGE CIRCLE
SAN DIEGO, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
IVAC MEDICAL SYSTEMS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does IVAC MEDICAL SYSTEMS, INC. have?
IVAC MEDICAL SYSTEMS, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 1 cancelled.
What trademark classes does IVAC MEDICAL SYSTEMS, INC. file in?
IVAC MEDICAL SYSTEMS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are IVAC MEDICAL SYSTEMS, INC.'s most well-known trademarks?
IVAC MEDICAL SYSTEMS, INC.'s registered trademark portfolio includes well-known marks such as ACCUSLIDE and SMARTSITE. These are among 2 currently registered trademarks in the portfolio.
What is IVAC MEDICAL SYSTEMS, INC.'s trademark registration success rate?
IVAC MEDICAL SYSTEMS, INC. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.